A recent groundbreaking study unveils the complex landscape of unmet medical needs among the global aging population, offering new insights that could reshape healthcare policy and delivery. The research, published in a leading geriatrics journal, meticulously analyzes data drawn from a comprehensive national health service survey, revealing both the distribution patterns and deep-rooted inequalities affecting older adults’ access to medical care.

As the world’s population ages, the demand for healthcare services tailored to older adults is rising dramatically. Yet, this study reveals that many older individuals face significant barriers that prevent them from receiving timely and adequate medical attention. Utilizing advanced statistical models and large-scale population data, researchers identified critical demographic and socioeconomic factors linked with these unmet needs.

The findings highlight that unmet medical needs are not uniformly distributed but vary substantially across different segments of the elderly population. Income disparity emerges as a predominant determinant, with lower-income groups disproportionately affected. These individuals often encounter limited access to healthcare facilities, affordability challenges, and reduced availability of specialized geriatric services.

Furthermore, geographic location plays a decisive role. Older adults living in rural or underserved regions exhibit much higher rates of unmet medical needs compared to their urban counterparts. The scarcity of healthcare providers and transportation difficulties exacerbate these disparities, underscoring the urgent necessity for targeted interventions in healthcare infrastructure.

Another critical element revealed by the study is the influence of social support structures. Elderly individuals with limited family support or social networks experience greater hurdles in managing chronic conditions and accessing preventive care. This dimension adds a nuanced layer to understanding the intersectionality of healthcare inequalities among seniors.

Technological and systemic barriers also contribute significantly. Despite advancements in telemedicine and digital health platforms, a considerable portion of the older population remains digitally excluded, preventing them from leveraging these new modes of healthcare delivery. This technological divide further entrenches existing healthcare inequalities.

The research team employed rigorous analytical techniques to control for confounding variables, thereby isolating the independent effects of various risk factors. Their approach not only quantifies the scope of unmet medical needs but also provides actionable insights for policymakers, healthcare providers, and social services.

In a call to action, the study emphasizes the importance of multidimensional strategies that address economic, geographic, social, and technological determinants simultaneously. Tailoring interventions to these complex factors is paramount in ensuring equitable healthcare access for older adults and ultimately enhancing their quality of life.

As global demographics shift, this study serves as a critical resource for stakeholders striving to promote health equity among the aging. The detailed evidence underscores an urgent need to rethink current healthcare models by incorporating comprehensive measures that bridge gaps and dismantle barriers to care.

Subject of Research:
Unmet medical needs and associated inequalities among older adults based on national health survey data.

Article Title:
Distribution, inequalities and associated factors of unmet medical needs among older adults: evidence from the national health service survey.

Article References:
Deng, Q., Yang, Y., Qiao, J. et al. Distribution, inequalities and associated factors of unmet medical needs among older adults: evidence from the national health service survey. BMC Geriatr (2026). https://doi.org/10.1186/s12877-026-07948-z

Image Credits: AI Generated

DOI: 10.1186/s12877-026-07948-z

Keywords:
Unmet medical needs, older adults, healthcare inequalities, geriatric health, socioeconomic factors, rural healthcare access, health services distribution

In a groundbreaking fusion of cutting-edge technology and dermatological research, scientists at Biohub have unveiled novel therapeutic targets for psoriasis by conducting the first comprehensive genome-wide CRISPR screen in primary human adult skin cells. By overcoming the longstanding technical hurdle of delivering CRISPR components into notoriously resistant keratinocytes without toxicity, the team utilized centrifuge-based transfection to probe the genetic regulators involved in psoriasis, a chronic inflammatory skin disorder affecting millions globally.

This innovative approach involved knocking out approximately 19,000 genes in keratinocytes sourced from human donors using a vast CRISPR guide RNA library. The focus was on modulating IL17RA, a pivotal receptor that mediates skin inflammation, to chart a genome-wide landscape of genes influencing inflammatory pathways directly in the skin’s outermost layer. The resultant massive data set was then mined using an AI-driven model, VirtualCRISPR, which cross-referenced each gene’s significance against existing scientific literature to highlight previously unrecognized contributors to psoriasis pathology.

Strikingly, this AI-guided screen pinpointed two promising protein targets: ALOX5, an enzyme targeted by the asthma medication zileuton, and OXTR, the gene encoding for the oxytocin receptor, a surprising candidate unassociated before with skin inflammation. Validation experiments in 3D reconstructed human skin cultures demonstrated that zileuton modulates keratinocyte metabolism to suppress inflammation independently from immune cells, revealing a direct pharmacological avenue.

Importantly, topical formulations containing zileuton and cligosiban, an OXTR antagonist, were tested in a mouse model of psoriasis, achieving comparable efficacy to standard injected biologics that broadly suppress immune function. Beyond mitigating inflammation, OXTR inhibition appeared to restore skin barrier integrity—a crucial factor in chronic disease progression—spotlighting this receptor as a novel therapeutic axis.

Unlike current systemic therapies, which often carry risks of broad immunosuppression and high costs, these localized topical interventions promise targeted treatment with minimal systemic exposure. Moreover, the safety profiles of zileuton and OXTR antagonists are well-established in clinical settings, potentially accelerating their repurposing for dermatological applications.

This study exemplifies the transformative power of integrating AI with high-dimensional genetic screening to unravel complex disease mechanisms in cell types previously inaccessible to large-scale functional genomics. By enabling direct investigation into keratinocyte biology, the research not only charts a course for new psoriasis treatments but also sets a precedent for applying similar methodologies to other inflammatory conditions.

As psoriasis affects roughly 125 million people worldwide, innovations enabling precise, effective, and safer therapies could revolutionize patient care. Biohub’s approach heralds a new era where AI-guided CRISPR screens expedite the discovery of unexpected drug targets and foster the development of locally acting, biology-informed treatments.

---

Subject of Research: Psoriasis therapeutic targets via genome-wide CRISPR screening of human skin cells

Article Title: AI-guided CRISPR screening reveals therapeutic targets in psoriasis

News Publication Date: 8-Jul-2026

Web References:
https://www.nature.com/articles/s41467-026-75249-5

References:
DOI: 10.1038/s41467-026-75249-5

Image Credits: Biohub

Keywords

Psoriasis, CRISPR, Oxytocin receptor, ALOX5, Zileuton, Cligosiban, Keratinocytes, AI-guided screening, Inflammation, Topical therapeutics

A groundbreaking study from Edith Cowan University (ECU) has demonstrated that a structured, midwife-led birth debrief significantly enhances women’s emotional wellbeing postpartum—a development that could redefine standard maternity care. Conducted at Fiona Stanley Hospital, this research tested a standardized conversation guide for birth debriefings, co-designed with midwives, healthcare managers, and maternity advocates to ensure clinical and emotional relevance.

The intervention centers on an emotionally safe, woman-led discussion facilitated by midwifery expertise and therapeutic communication techniques. According to ECU Research Fellow Dr. Kate Buchanan, such debriefings empower women to reflect on and make sense of their childbirth experience, addressing unresolved questions or distress that may persist after hospital discharge. This approach contrasts markedly with typical critical incident debriefs, which focus on clinical review and involve medical staff rather than midwives, and psychological debriefings aimed solely at trauma patients.

Over 100 women participated in the pilot, reporting high satisfaction levels with the midwife-led conversations. Many described the experience as clarifying, validating, and empowering. Participants particularly valued having the discussion with a midwife they already knew, underlining the importance of continuity of care in emotional processing. Dr. Buchanan highlights that midwives, with their holistic understanding of birth as a profound life event, are uniquely positioned to foster this dialogue.

Significantly, the study underscores the potential of midwife-led debriefs to mitigate birth trauma, a condition affecting roughly 30% of women globally. Women who self-identified as having experienced birth trauma rated the opportunity to talk about their birth with a midwife as the most beneficial aspect of the intervention. This therapeutic exchange may offer relief by deepening understanding of the birth events and connecting mothers to further psychological support if needed.

Despite the additional time and resource investment required, hospital management at Fiona Stanley confirmed the intervention’s feasibility and sustainability, emphasizing the importance of allocated time and ongoing training for midwives. The potential long-term benefits, including reductions in mental health burdens and healthcare costs associated with untreated birth trauma, offer compelling justification for integrating debriefs into routine postnatal care.

This innovative research contributes to expanding the global movement toward integrating psychosocial care within maternal health services. By establishing a replicable model that combines clinical expertise with patient-centered communication, the study positions midwife-led birth debriefing as an essential standard in supporting maternal mental health.

The findings were published in BMC Public Health under the title “Co-design and feasibility testing of a midwife-led birth debrief: an implementation science project,” funded by the Women and Infants Research Foundation. As the movement toward holistic postpartum care gains momentum, this study cements the critical role of midwives not only as birth attendants but also as key agents of emotional support in women’s transition to motherhood.

---

Subject of Research: People
Article Title: Co-design and feasibility testing of a midwife-led birth debrief: an implementation science project
News Publication Date: 16-Apr-2026
Web References: https://doi.org/10.1186/s12889-026-27342-z
Keywords: Maternal mental health, birth trauma, midwife-led intervention, postpartum care, psychosocial support, implementation science

Exclusive: Campaigners argue news channel’s attacks on climate action ‘work in financial interests’ of Sir Paul Marshall

The hedge fund run by the co-owner of GB News almost tripled its investments in fossil fuel companies in the first quarter of 2026 to $2.8bn (£2.1bn), the Guardian can reveal.

Critics have accused Sir Paul Marshall of “cashing in on climate chaos” and have claimed the news channel, which frequently attacks climate science and action, was “working in its owner’s financial interests”.

Continue reading...

© Photograph: Anna Gordon

© Photograph: Anna Gordon

© Photograph: Anna Gordon

Japan’s Hayabusa 2 mission has revealed another "snowman" asteroid — a pair of asteroids attached with a narrow neck. The contact binary could help shed light on planet formation.

The post Hayabusa 2 Completes Flyby Past Asteroid Torifune appeared first on Sky & Telescope.

For decades, the scientific community has recognized the gut microbiome—the intricate ecosystem of bacteria and microorganisms residing within the human intestine—as a potential key player in colorectal cancer development. Yet, the complexity and variability of microbiome data have often obscured clear, reproducible links. Now, an ambitious new study spearheaded by the Mi-EOCRC consortium, which includes pioneering teams at EMBL Heidelberg, has transcended these obstacles by analyzing an unprecedented breadth of data to unearth a universal microbiome signature associated with colorectal cancer.

Garnering insights from an extensive meta-analysis of 27 studies with over 6,700 gut microbiome profiles, the researchers uncovered microbial patterns that remain consistent across diverse populations, sequencing methodologies, and age groups—illuminating a microbial footprint intrinsic to colorectal cancer itself. Their integrative approach not only encompassed stool samples but also expanded to 906 intestinal tissue specimens, revealing striking similarities between microbes colonizing tumors and those present in fecal matter.

This landmark research fundamentally shifted microbiome science by developing innovative computational tools capable of harmonizing heterogeneous datasets produced by different sequencing technologies. Such methodological rigor was critical in overcoming previous barriers of reproducibility that have long plagued microbiome studies. Central to their approach was a bespoke machine learning algorithm adept at categorizing microbiomes along a continuum from ‘healthy’ to ‘cancer-like,’ yielding a quantifiable score that can be leveraged across disparate human gut microbiome datasets, including those derived from dietary interventions.

This algorithmic precision allowed the consortium to isolate a colorectal cancer-associated microbiome signature that transcends traditional cohort boundaries. Intriguingly, the signature appears robust not only in late-stage disease but also in early-onset cases, dispelling prior uncertainty surrounding the microbiome’s role throughout the disease timeline. The discovery underscores the microbiome’s potential as an informative biomarker capable of reflecting the intricate disease ecology.

Moreover, by comparing tumor tissue microbial profiles with those detected in stool, the study illuminated how colorectal cancer’s microbial hallmarks are mirrored across sample types. Although the microbial signature was more readily detectable in advanced tumors or those proximal to the rectum, early-stage lesions exhibited a detectable microbial presence as well. This finding deepens our understanding of tumor-microbiome crosstalk and raises critical questions regarding how microbial communities might influence tumor progression via metabolic and signaling pathways.

Despite these advances, the researchers caution that pre-cancerous adenomas—often the target of preventive strategies—remain notoriously elusive in stool-derived microbiome analyses. The microbial alterations associated with adenomas were subtler and less consistent than those observed in full-fledged cancers. Sophisticated machine learning models specifically aimed at adenoma detection showed variable success across cohorts, highlighting the need for methodological refinement before such tools can make meaningful clinical contributions.

Diet emerged as another pivotal factor shaping cancer-associated microbial patterns. A compelling link was established between low dietary fiber intake and a heightened presence of the colorectal cancer microbiome signature. Conversely, dietary interventions increasing fiber consumption correlated with marked reductions in this cancer-associated microbial pattern. These findings reinforce the concept that diet—and particularly fiber—modulates the gut environment in ways that could impact cancer risk and progression, opening avenues for microbiome-focused preventive strategies rooted in nutrition.

Delving further into microbial taxonomy, the study provided high-resolution insights into Fusobacterium species, bacteria recurrently implicated in colorectal cancer. The researchers delineated notable differences among subspecies, with Fusobacterium nucleatum subsp. animalis exhibiting consistent cancer enrichment worldwide, whereas others showed distinct geographic distributions, predominantly in Asian populations. This nuanced understanding challenges the oversimplification of grouping all Fusobacteria uniformly and underscores the importance of subspecies-level resolution for future microbiome research and therapeutic targeting.

Open science was a cornerstone of this monumental undertaking. By consolidating thousands of publicly available microbiome profiles, the researchers achieved a scale of analysis previously unattainable, setting a new standard for evidence synthesis in microbiome studies. This collective data sharing facilitates reproducible science and paves the way for scalable, global approaches to understanding the microbiome’s role in human disease.

While the study stops short of proposing an immediate diagnostic application, it lays critical groundwork for the development of microbiome-informed clinical tools. Compared to existing non-invasive colorectal cancer screening tests like the fecal immunochemical test, microbiome-based classifiers are not yet on par for sensitivity or specificity. However, the reproducible microbial signature defined here could serve as a foundational reference for future machine-learning models, enabling improved risk stratification and early detection when integrated with other clinical markers.

The implications of this research ripple beyond colorectal cancer alone. The computational tools and conceptual frameworks unveiled may be applied to myriad disease contexts where the microbiome plays a role. Furthermore, the iterative feedback loop between dietary modulation and microbial signatures encourages a personalized medicine approach that incorporates lifestyle factors into disease management.

Finally, this research highlights the intricate dance between host, microbes, and environment that shapes disease landscapes. As microbiome science marches forward, studies like this exemplify the power of interdisciplinary collaboration, computational innovation, and open data stewardship to unravel complex biomedical puzzles, bringing us closer to novel interventions and preventive strategies that could transform patient outcomes worldwide.

Subject of Research: People
Article Title: Meta-analysis reveals microbiome signatures for colorectal cancer that are universal across onset age and sequencing method
News Publication Date: 24-Jun-2026
Web References: http://dx.doi.org/10.1016/j.chom.2026.05.030
Image Credits: Daniela Velasco/EMBL
Keywords: Colorectal cancer, Human microbiota, Gut microbiota

Voyager aux États-Unis, au Canada ou au Mexique pendant l’été implique souvent le même besoin : rester connecté sans se compliquer la vie. Entre la recherche d’itinéraires, les réservations de dernière minute, les messages aux proches et l’usage constant des applications de navigation, la...

Le RoboUP Raccoon 2 SE démocratise un peu plus l’accès aux robots tondeuses intelligents. Destiné aux jardins jusqu’à 600 m², ce modèle séduit par son fonctionnement sans câble périphérique et sa navigation assistée par caméra. À l’occasion du Prime Day Amazon, il profite d’une remise...

In a groundbreaking longitudinal study encompassing nearly half a million individuals, researchers have unveiled intricate patterns and biological underpinnings that link cardiometabolic diseases (CMDs) and depression. These two prevalent and often coexisting health conditions have long posed challenges due to their complex interaction and compounded risk on mortality. Now, through a multinational, multi-omic analytic approach, this study sheds new light on how these diseases develop, interlace over time, and ultimately impact life expectancy, offering hope for earlier detection and more precise interventions.

Cardiometabolic diseases—which include chronic conditions such as cardiovascular disease, type 2 diabetes, and metabolic syndrome—are among the leading causes of death globally. Depression, meanwhile, remains a colossal mental health burden, often running parallel to various physical ailments. The coexistence, or multimorbidity, of CMDs and depression exacerbates health outcomes significantly, yet the trajectory of how one condition progresses to include the other and the biological mechanisms driving this interaction have remained elusive.

Leveraging data from the UK Biobank, the largest population-based health cohort, the study followed 467,592 participants initially free of both CMD diagnoses and depression. Over a 14.6-year period, the scientists meticulously chronicled disease transitions using advanced multistate models. These allowed them not only to identify disease onset patterns but also to map complex pathways outlining progression from health to single disease states and then to multimorbidity.

The findings revealed that within the follow-up window, more than 64,000 participants developed CMD alone, while approximately 17,500 were diagnosed with depression exclusively. Crucially, over 6,100 individuals progressed to multimorbidity, reflecting the convergence of these conditions in a significant subset of the population. Importantly, the risk of subsequently developing the alternate condition was substantially elevated for those already affected by either CMD or depression, underscoring the bidirectional relationship between physical and mental health.

Further delving into survival outcomes, the researchers observed that individuals with multimorbidity faced a 13 to 22 percent increase in mortality risk compared to those free of disease, accompanied by a marked reduction in life expectancy averaging between 3.6 to 3.8 years. Such stark contrasts reinforce the clinical urgency of understanding and managing the intersection of CMDs and depression rather than treating them in isolation.

However, a nuanced discovery emerged from the survival analysis: the mortality impact of coexisting CMD and depression appeared additive rather than synergistic. This suggests that while coexistence heightens risk, the two diseases may operate through largely independent pathways driving mortality, a revelation that could recalibrate how treatment priorities are structured.

To decipher biological signatures predictive of disease progression and multimorbidity, the study incorporated multi-omics platforms—comprehensive analyses including proteomics, metabolomics, genomics, and methylomics. These high-dimensional tools allow scientists to detect subtle molecular changes reflecting pathophysiological shifts and prognostic biomarkers far earlier than clinical symptoms emerge.

Remarkably, proteomic models stood out in their predictive prowess. When applied to the 15-year risk horizon for CMD-depression transitions, these models achieved area-under-the-curve (AUC) values ranging between 0.70 and 0.91. This performance significantly eclipsed that of traditional clinical risk models, heralding a new dawn where molecular profiling could transform risk stratification and preventive strategies.

Distinct multi-omic signatures were identified at each disease transition point—whether from health to CMD alone, health to depression alone, or the combined pathway leading to multimorbidity. These signatures could reflect unique biological processes such as inflammatory cascades, metabolic dysregulation, neuroendocrine changes, or immune system perturbations, each contributing distinctively to disease progression.

The implications of these findings are far-reaching. With multimorbidity presenting as a growing global health challenge, understanding its trajectory and molecular footprints empowers clinicians and researchers to design targeted interventions that transcend symptom management. Early identification of individuals at highest risk via omic biomarkers could enable precision medicine approaches that pre-empt illness onset or halt progression.

Furthermore, by elucidating the distinct yet interconnected biological pathways linking CMDs and depression, this research challenges the traditionally siloed view of mental and physical health. It advocates for integrated care models that address the whole person rather than fragmented disease entities, a paradigm shift essential for improving patient outcomes in real-world settings.

The study also leverages rigorous multistate modeling, a sophisticated statistical technique allowing for dynamic representation of illness progression over time. This approach captures the complexity inherent in chronic disease trajectories, encompassing not only onset but transitions between disease states and eventual mortality. Such modeling enhances the granularity of epidemiological insights far beyond conventional methods.

As large-scale biobanks increasingly incorporate multi-omic data, the ability to unravel disease biology at unprecedented depth will only grow. The present study exemplifies how marrying big data with cutting-edge analytic frameworks can unveil novel insights into multimorbidity, transforming epidemiology into a powerful tool for precision health.

This research arrives at a critical juncture where global populations face rising burdens of chronic diseases intertwined with mental health challenges. Targeted, biologically informed strategies could ease the strain on healthcare systems and improve quality of life for millions living with overlapping disease burdens.

While promising, the findings also urge cautious optimism. The translation of molecular signatures into routine clinical tools requires further validation and contextualization across diverse ancestral and environmental backgrounds. However, these initial steps firmly establish a conceptual blueprint for future studies to build upon.

Taken together, this extensive investigation pioneers a new frontier in understanding the intertwined evolution of cardiometabolic diseases and depression. By uniting longitudinal clinical data with multi-omics analyses and sophisticated modeling, it heralds a transformative approach toward unraveling multimorbidity’s mysteries and paves the way for early, targeted prevention.

The convergence of CMDs and depression, previously viewed as a devastating clinical overlap, now emerges as a tractable problem awaiting targeted intervention—fueling hope that integrated molecular insights will soon translate into lifesaving real-world applications. This revolutionary research sets the stage for a future where vulnerability to complex chronic disease is revealed well before symptoms arise, opening unprecedented avenues for personalized health preservation.

Subject of Research:
Multi-omic signatures and disease trajectories linking cardiometabolic diseases and depression

Article Title:
Multi-omic signatures and trajectories of cardiometabolic diseases and depression

Article References:

Yang, G., Jiang, X., Wang, J. et al. Multi-omic signatures and trajectories of cardiometabolic diseases and depression.
Nat. Mental Health (2026). https://doi.org/10.1038/s44220-026-00678-6

Image Credits: AI Generated

DOI:
https://doi.org/10.1038/s44220-026-00678-6

A yet unnamed Australian spider weaponizes silk to hunt a single ant species.

À l’occasion du World Youth Skills Day, Hostinger met en avant une offre pensée pour celles et ceux qui veulent transformer une idée en présence en ligne concrète. Portfolio créatif, CV interactif, mini-site personnel ou page de présentation : l’objectif est simple, rendre la publication web...

Les beaux jours sont souvent l’occasion de passer davantage de temps à l’extérieur. Avec ces cinq spas gonflables à moins de 400 €, il devient possible de profiter de moments de détente et de bien-être à domicile sans faire exploser son budget.

À l’occasion du MWC Shanghai 2026, Orange met en avant une vision de la 5G pensée pour accompagner la montée en puissance des usages mobiles intensifs. Streaming en haute définition, jeux en ligne, visioconférences professionnelles ou partage de connexion permanent : les réseaux sont aujourd’hui...

Le robot piscine Dreame Z1 attire actuellement de nombreux regards sur Amazon, notamment grâce à une remise de 50 % qui fait passer son prix sous la barre des 500 €. Une offre qui risque de ne pas rester longtemps disponible. Sans fil, il prend en charge le nettoyage du fond, des parois et de la...

Les robots aspirateurs laveurs sont devenus de véritables alliés du quotidien pour garder une maison propre sans effort. Parmi les marques les plus réputées du secteur, Roborock s'est imposée grâce à des appareils performants, intelligents et particulièrement efficaces sur tous types de sols.

Amazon frappe fort à l’occasion du Prime Day avec une baisse de prix notable sur le spa gonflable Bestway Lay-Z-Spa Milan AirJet Plus. Capable d’accueillir jusqu’à six personnes, ce modèle transforme facilement un coin de jardin ou une terrasse en espace de détente. Entre bulles relaxantes, eau...

Avec les fortes chaleurs estivales, rien de tel que de savourer des glaces, sorbets ou desserts glacés faits maison. La sorbetière Moulinex Dolci MJ602AF0 a justement été pensée pour permettre à toute la famille de réaliser facilement des préparations gourmandes tout au long de l'été, avec un...

L’iPhone 17 fait partie des smartphones les plus convoités du moment. Avec son design premium, ses performances de haut niveau et son écosystème toujours aussi fluide, il s’impose comme un choix de premier ordre pour les utilisateurs à la recherche d’un appareil durable et performant au quotidien.

Fin mai, le thermomètre a frôlé les 40 °C en France, confirmant l’urgence climatique après les étés étouffants de 2023 et 2025. Pour le secteur du BTP, la chaleur ne peut plus être gérée au coup par coup. Vinci, Bouygues, Eiffage… entre nouvelles obligations légales et retours d’expérience de...